Target intelligence / Profile preview

Eukaryotic translation initiation factor 3 subunit F pseudogene 3 (EIF3FP3)

Target
EIF3FP3
Molecular classification
Other (Pseudogene)
01

Overview

EIF3FP3 is a human pseudogene, named for its sequence similarity to "eukaryotic translation initiation factor 3 subunit F" (EIF3F)[2][3]. Pseudogenes such as EIF3FP3 do not code for functional proteins and are generally not considered therapeutic targets, biological markers, or contributors to disease pathogenesis. They may originate from gene duplication or retrotransposition events but typically lack the necessary elements for correct expression and protein production. There is no evidence indicating EIF3FP3 is expressed or functional; its primary significance is as a genomic sequence related to EIF3F, the true protein-coding gene that is a subunit of a critical translation initiation complex[3][1]. No drug interactions, biomarkers, disease associations, or safety concerns are documented for EIF3FP3, and it is not targeted in current therapeutic or diagnostic applications. There is something wrong with this target for most research and clinical uses: EIF3FP3 is not a functional protein, receptor, or enzyme—instead, it is a pseudogene. Any reference to using EIF3FP3 as a drug target, biomarker, or functional molecular entity is incorrect. If information regarding translation initiation, disease association, or drug interactions is needed, it should relate to the canonical functional gene EIF3F (eukaryotic translation initiation factor 3 subunit F), not the pseudogene variant.

Other names
hCG15200EIF3FP3

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 3 subunit F pseudogene 3 (EIF3FP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit F pseudogene 3 (EIF3FP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call